Geratherm Medical AG Market Cap ($13.48 Million)
Market Cap & Net Worth: Geratherm Medical AG (GME)
Geratherm Medical AG market cap. Geratherm Medical AG (XETRA:GME) has a market capitalization of $13.48 Million (€11.53 Million) as of November 4, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #26154 globally and #2241 in its home market, demonstrating a -4.91% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Geratherm Medical AG's stock price €2.13 by its total outstanding shares 5411945 (5.41 Million). Also see cash flow conversion of Geratherm Medical AG for how efficiently the company converts equity into cash flow.
Geratherm Medical AG Market Cap History (2015–2026)
Geratherm Medical AG market cap history from 2015 to 2026. Data shows change from $50.51 Million to $13.48 Million (-11.27% CAGR). Check Geratherm Medical AG stock price for real-time trading data and today's change.
Geratherm Medical AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Geratherm Medical AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Geratherm Medical AG to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.08x
Geratherm Medical AG's market cap is 1.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
31.22x
Geratherm Medical AG's market cap is 31.22 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $50.51 Million | $21.59 Million | $2.70 Million | 2.34x | 18.70x |
| 2016 | $56.74 Million | $22.06 Million | $2.24 Million | 2.57x | 25.37x |
| 2017 | $60.64 Million | $21.03 Million | $679.79K | 2.88x | 89.21x |
| 2018 | $46.21 Million | $21.52 Million | $1.15 Million | 2.15x | 40.06x |
| 2019 | $46.29 Million | $19.85 Million | $289.86K | 2.33x | 159.71x |
| 2020 | $62.37 Million | $27.47 Million | $2.05 Million | 2.27x | 30.50x |
| 2021 | $49.71 Million | $24.64 Million | $122.23K | 2.02x | 406.64x |
| 2022 | $30.09 Million | $25.85 Million | $1.02 Million | 1.16x | 29.40x |
| 2023 | $33.29 Million | $20.96 Million | $1.11 Million | 1.59x | 29.96x |
| 2024 | $22.02 Million | $20.43 Million | $705.17K | 1.08x | 31.22x |
Competitor Companies of GME by Market Capitalization
Companies near Geratherm Medical AG in the global market cap rankings as of November 4, 2026. Also see balance sheet size of Geratherm Medical AG for a full breakdown of the balance sheet.
Key companies related to Geratherm Medical AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Geratherm Medical AG (2015–2026)
Market capitalization of Geratherm Medical AG from 2015 to today. Between 2015 and today, Geratherm Medical AG's market cap moved from $50.51 Million to $ 13.48 Million, with a yearly change of -11.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €13.48 Million | -26.30% |
| 2025 | €18.29 Million | -16.95% |
| 2024 | €22.02 Million | -33.87% |
| 2023 | €33.29 Million | +10.66% |
| 2022 | €30.09 Million | -39.47% |
| 2021 | €49.71 Million | -20.31% |
| 2020 | €62.37 Million | +34.74% |
| 2019 | €46.29 Million | +0.18% |
| 2018 | €46.21 Million | -23.80% |
| 2017 | €60.64 Million | +6.88% |
| 2016 | €56.74 Million | +12.34% |
| 2015 | €50.51 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Geratherm Medical AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.48 Million USD |
| MoneyControl | $13.48 Million USD |
| MarketWatch | $13.48 Million USD |
| marketcap.company | $13.48 Million USD |
| Reuters | $13.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Geratherm Medical AG
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnosti… Read more